Husereau, D.; Bombard, Y.; Stockley, T.; Carter, M.; Davey, S.; Lemaire, D.; Nohr, E.; Park, P.; Spatz, A.; Williams, C.;
et al. Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective. Curr. Oncol. 2023, 30, 9660-9669.
https://doi.org/10.3390/curroncol30110700
AMA Style
Husereau D, Bombard Y, Stockley T, Carter M, Davey S, Lemaire D, Nohr E, Park P, Spatz A, Williams C,
et al. Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective. Current Oncology. 2023; 30(11):9660-9669.
https://doi.org/10.3390/curroncol30110700
Chicago/Turabian Style
Husereau, Don, Yvonne Bombard, Tracy Stockley, Michael Carter, Scott Davey, Diana Lemaire, Erik Nohr, Paul Park, Alan Spatz, Christine Williams,
and et al. 2023. "Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective" Current Oncology 30, no. 11: 9660-9669.
https://doi.org/10.3390/curroncol30110700
APA Style
Husereau, D., Bombard, Y., Stockley, T., Carter, M., Davey, S., Lemaire, D., Nohr, E., Park, P., Spatz, A., Williams, C., Pollett, A., Lo, B., Yip, S., El Hallani, S., & Feilotter, H.
(2023). Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective. Current Oncology, 30(11), 9660-9669.
https://doi.org/10.3390/curroncol30110700
